Smad signal transduction pathway involved in supression of VEGF on TGF-β1 induced EMT of HK-2 cells
Zheng Fa-lei
Abstract
Zheng Fa-lei
Abstract
Objective To examine the relationship between the inhibitory effect of VEGF on EMT of HK-2 cells and the influence of changes in the expressions of SnoN and Smad pathway on the effect of VEGF mentioned above. Methods The cultured HK-2 cells were divided into four groups:①without treatment group, ②treated with TGF-β1 (5 μg/L) alone as positive control group, ③ treated with VEGF165 (100 μg/L) alone group, ④treated with TGF-β1 (5 μg/L) and VEGF165 (100 μg/L) as the co-treatment group. The α-SMA, p-Smad 2/3 and Smad 2/3, Smad 7, SnoN expressions were assessed with western blot and RT-PCR, respectively. Results By western blot and RT-PCR analysis, it's found α-SMA expression was significantly increased in HK-2 cells treated with TGF-β1 (5 μg/L) compared with no treatment (P 0.05), and the ratio of p-Smad 2/3 and Smad 2/3 were significantly increased in both 30 min and 60 min (P 0.05). These phosphorylation marker mentioned above decreased in HK-2 cells co-treatment group compared with the positive controls, especially at 30 min (P 0.05). But Smad 7 expression was exactly opposite to that of these phosphorylation marker mentioned above. VEGF165 dramatically abrogated TGF-β1 induced α-SMA expression and phosphorylation of Smad 2/3 and restored Smad 7 expression in HK-2 cells (P 0.05). However, VEGF165 itself failed to induce phosphorylation of Smad 2/3 and the expression of Smad 7. SnoN protein expression significantly increased in HK-2 cells treated with TGF-β1 (5 μg/L) compared with no treatment (P 0.05) patients, but was not different in HK-2 cells co-treatment patients compared with positive controls(P ﹥0.05). SnoN mRNA expression was not significantly different in all groups (P ﹥0.05). Conclusions The results documented that VEGF165 may partially inhibit TGF-β1-induced EMT in HK-2 cells in vitro, and this effect is related to suppress of phosphorylation of Smad 2/3 directly, and up-regulates Smad 7 expression. However, the effect of VEGF165 on EMT may be not related to SnoN expression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To examine the relationship between the inhibitory effect of VEGF on EMT of HK-2 cells and the influence of changes in the expressions of SnoN and Smad pathway on the effect of VEGF mentioned above. Methods The cultured HK-2 cells were divided into four groups:①without treatment group, ②treated with TGF-β1 (5 μg/L) alone as positive control group, ③ treated with VEGF165 (100 μg/L) alone group, ④treated with TGF-β1 (5 μg/L) and VEGF165 (100 μg/L) as the co-treatment group. The α-SMA, p-Smad 2/3 and Smad 2/3, Smad 7, SnoN expressions were assessed with western blot and RT-PCR, respectively. Results By western blot and RT-PCR analysis, it's found α-SMA expression was significantly increased in HK-2 cells treated with TGF-β1 (5 μg/L) compared with no treatment (P 0.05), and the ratio of p-Smad 2/3 and Smad 2/3 were significantly increased in both 30 min and 60 min (P 0.05). These phosphorylation marker mentioned above decreased in HK-2 cells co-treatment group compared with the positive controls, especially at 30 min (P 0.05). But Smad 7 expression was exactly opposite to that of these phosphorylation marker mentioned above. VEGF165 dramatically abrogated TGF-β1 induced α-SMA expression and phosphorylation of Smad 2/3 and restored Smad 7 expression in HK-2 cells (P 0.05). However, VEGF165 itself failed to induce phosphorylation of Smad 2/3 and the expression of Smad 7. SnoN protein expression significantly increased in HK-2 cells treated with TGF-β1 (5 μg/L) compared with no treatment (P 0.05) patients, but was not different in HK-2 cells co-treatment patients compared with positive controls(P ﹥0.05). SnoN mRNA expression was not significantly different in all groups (P ﹥0.05). Conclusions The results documented that VEGF165 may partially inhibit TGF-β1-induced EMT in HK-2 cells in vitro, and this effect is related to suppress of phosphorylation of Smad 2/3 directly, and up-regulates Smad 7 expression. However, the effect of VEGF165 on EMT may be not related to SnoN expression.
Key concepts: SMAD, Phosphorylation, Western blot, Medicine, Signal transduction, Smad2 Protein, Blot, Internal medicine